|
|
|
|
|
by thaumasiotes
45 days ago
|
|
> The high interest environment means that biotech investing has been hit extremely hard I don't think this reasoning can work. To the extent these things are directly related, the relationship would have to be: returns on investment are at an all-time high --> more investing than usual. |
|
When interest rates are high, capital shifts to yield-generating, interest-bearing investments. They give higher returns with less risk.
So basically the ROI of biotech becomes less competitive compared to alternatives. You have the same number of people/firms chasing a smaller supply of investment dollars.